Climb Bio, Inc.
Clinical-stage biotech developing monoclonal antibodies for immune-mediated diseases.
CLYM | NDAQ
Overview
Corporate Details
- ISIN(s):
- US28658R1068
- LEI:
- Country:
- United States of America
- Address:
- 20 WILLIAM STREET, 2481 WELLESLEY HILLS
- Website:
- https://climbbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Climb Bio, Inc. is a clinical-stage biotechnology company dedicated to developing high-impact, disease-modifying medicines for patients with immune-mediated diseases. The company's scientific approach focuses on creating differentiated monoclonal antibodies to address conditions with limited therapeutic options. Its pipeline consists of investigational therapies advancing through clinical studies in multiple disease areas. Climb Bio aims to improve clinical outcomes and provide patients more time free from their disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Climb Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Climb Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Climb Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Ltd/other/HUTCHMED_China_Ltd-logo.png){kind=logo}
